Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Falciani

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
A novel super-potent neurokinin A receptor antagonist containing dehydroalanineA Lombardi, B D'Agostino, F Nastri, et al.
FEBS Letters|August 10, 2000
A mutation in the pleckstrin homology (PH) domain of the FGD1 gene in an Italian family with faciogenital dysplasia (Aarskog-Scott syndrome)A Orrico, L Galli, M Falciani, et al.
British Journal of Haematology|May 25, 2002
Tissue factor and tissue factor pathway inhibitor levels in unstable angina patients during short-term low-molecular-weight heparin administrationA M Gori, S Fedi, G Pepe, et al.
Farmaco (Societa Chimica Italiana : 1989)|September 1, 1994
Synthesis and pharmacological activities of ethyl 5-cyano-1,6-dihydro-6-oxo-2-(2,3,4-pyridyl)-3-pyridinecarboxylates and derivativesL Mosti, P Schenone, M M Mahiques, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Neuronorm is a potent and water soluble neurokinin A receptor antagonistA Lombardi, B D'Agostino, A Filippelli, et al.
World Journal of Gastroenterology|July 31, 2007
Platelet aggregation is affected by nitrosothiols in patients with chronic hepatitis: in vivo and in vitro studiesA Federico, A Filippelli, M Falciani, et al.
Thrombosis and Haemostasis|September 24, 1999
Percutaneous transluminal coronary angioplasty procedure is associated to a decrease in transforming growth factor beta 1 levelsM Falciani, A M Gori, B Giusti, et al.
Thrombosis and Haemostasis|July 15, 1999
Procedure-dependence and tissue factor-independence of hypercoagulability during orthopaedic surgeryS Fedi, A M Gori, M Falciani, et al.
Thrombosis and Haemostasis|April 8, 1998
Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patientsM Falciani, A M Gori, S Fedi, et al.
Thrombosis and Haemostasis|May 11, 1999
Tissue factor reduction and tissue factor pathway inhibitor release after heparin administrationA M Gori, G Pepe, M Attanasio, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
A novel super-potent neurokinin A receptor antagonist containing dehydroalanineA Lombardi, B D'Agostino, F Nastri, et al.
FEBS Letters|August 10, 2000
A mutation in the pleckstrin homology (PH) domain of the FGD1 gene in an Italian family with faciogenital dysplasia (Aarskog-Scott syndrome)A Orrico, L Galli, M Falciani, et al.
British Journal of Haematology|May 25, 2002
Tissue factor and tissue factor pathway inhibitor levels in unstable angina patients during short-term low-molecular-weight heparin administrationA M Gori, S Fedi, G Pepe, et al.
Farmaco (Societa Chimica Italiana : 1989)|September 1, 1994
Synthesis and pharmacological activities of ethyl 5-cyano-1,6-dihydro-6-oxo-2-(2,3,4-pyridyl)-3-pyridinecarboxylates and derivativesL Mosti, P Schenone, M M Mahiques, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Neuronorm is a potent and water soluble neurokinin A receptor antagonistA Lombardi, B D'Agostino, A Filippelli, et al.
World Journal of Gastroenterology|July 31, 2007
Platelet aggregation is affected by nitrosothiols in patients with chronic hepatitis: in vivo and in vitro studiesA Federico, A Filippelli, M Falciani, et al.
Thrombosis and Haemostasis|September 24, 1999
Percutaneous transluminal coronary angioplasty procedure is associated to a decrease in transforming growth factor beta 1 levelsM Falciani, A M Gori, B Giusti, et al.
Thrombosis and Haemostasis|July 15, 1999
Procedure-dependence and tissue factor-independence of hypercoagulability during orthopaedic surgeryS Fedi, A M Gori, M Falciani, et al.
Thrombosis and Haemostasis|April 8, 1998
Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patientsM Falciani, A M Gori, S Fedi, et al.
Thrombosis and Haemostasis|May 11, 1999
Tissue factor reduction and tissue factor pathway inhibitor release after heparin administrationA M Gori, G Pepe, M Attanasio, et al.
Pageof 4